
<!DOCTYPE html>
<html lang="en">
<head>
    <link href="https://fonts.googleapis.com/css2?family=Roboto:wght@400;700&display=swap" rel="stylesheet">
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Zuzanna Nowicka</title>
    <style>
        body {
            font-family: 'Roboto', sans-serif;
            margin: 0;
            padding: 0;
            background-color: #ffffff;
            color: #333;
            display: flex;
            flex-direction: column; /* Stack the header and main content */
        }

        header {
            background: linear-gradient(90deg, #680505, #774545);
            color: rgb(255, 255, 255);
            padding: 2rem 0;
            text-align: center;
            width: 100%;
            box-sizing: border-box;
            position: relative;
        }

        .main-container {
            display: flex;
            width: 100%;
        }

        .sidebar {
            width: 50%;
            background-color: #f4f4f4;
            padding: 2rem;
            box-shadow: 2px 0 5px rgba(0, 0, 0, 0.1);
        }

        .sidebar img {
            width: 100%;
            border-radius: 0; /* No circle */
            margin-bottom: 1rem;
        }

        .sidebar h2 {
            font-size: 1.8rem;
            color: #680505;
            margin-bottom: 1rem;
        }

        .content {
            flex-grow: 1;
            padding: 0 2rem;
        }

        section {
            margin-bottom: 2rem;
        }

        h2 {
            color: #0b0b0b;
            font-size: 1.5rem;
            border-bottom: 2px solid #000000;
            padding-bottom: 0.5rem;
        }

        ul {
            list-style: none;
            padding: 0;
        }

        li {
            margin: 0.5rem 0;
        }

        a {
            text-decoration: none;
            color: #000000;
        }

        a:hover {
            text-decoration: underline;
        }

        footer {
            background: #680505;
            color: white;
            text-align: center;
            padding: 1rem 0;
            margin-top: 2rem;
        }
    </style>
</head>
<body>
    <header>
        <h1></h1>
    </header>
    <div class="main-container">
        <div class="sidebar">
            <img src="https://github.com/zuzannow/zuzannow.github.io/blob/main/Zuzanna.png?raw=true" alt="Zuzanna Nowicka">
            <h2>Zuzanna Nowicka</h2>
        </div>
        <div class="content">
            <main>
                <section>
                    <h2>About Me</h2>
                    <p>Hi! I am MD and fourth year Ph.D. student at Medical University of Lodz, Poland.</p>
                    <p>I am doing my Ph.D. at Department of Biostatistics and Translational Medicine and I am broadly interested in using statistics, bioinformatics and mathematical modeling to uncover the connections between DNA damaging agents in cancer and adaptive immunity. I am also interested in statistical design of clinical trials.</p>
                    <p>My research so far focused on Radiation Oncology and biomarker research, but I am soon starting my residence in Hematology.</p>
                </section>
                <section>
                    <h2>Links</h2>
                    <ul>
                        <u><li><a href="https://scholar.google.pl/citations?user=52Ser5sAAAAJ&hl=pl" target="_blank">Google Scholar</a></li></u>
                        <u><li><a href="https://www.researchgate.net/profile/Zuzanna_Nowicka2" target="_blank">ResearchGate</a></li></u>
                    </ul>
                </section>
                <section>
                    <h2>Selected Papers</h2>
                    <p>1. Pastorczak A, Urbanska Z, Styka B, Miarka-Walczyk K, Sedek L, Wypyszczak K, Wakulinska A, <b>Nowicka Z</b>, Szczepański T, Stańczak M, Fendler W, Kowalczyk J, Młynarski W, Lejman M.
                        <i>Genetic hallmarks and clinical implications of chromothripsis in childhood T-cell acute lymphoblastic leukemia.</i>Leukemia. 2024 Nov;38(11):2344-2354. doi: 10.1038/s41375-024-02370-z</p>
                    <p>2. Sun Y, Patterson-Fortin J, Han S, Li Z, <b>Nowicka Z</b>, Hirohashi Y, Kilgas S, Yi JK, Spektor A, Fendler W, Konstantinopoulos PA, Chowdhury D. <i>53BP1 loss elicits cGAS-STING-dependent antitumor immunity in ovarian and pancreatic cancer.</i>
                        Nat Commun. 2024 Aug 6;15(1):6676. doi: 10.1038/s41467-024-50999-2</p>
                    <p>3. <b>Nowicka Z</b>, Kuna K, Łaszczych M, Łazar-Poniatowska M, Sobocki BK, Stawiski K, Dąbrowski M, Bruski K, Zięba A, Pajdziński M, Staniewska E, Miszczyk M, Paganetti H, Fendler W, Tomasik B. <i>Dose-volume metric-based prediction of radiotherapy-induced lymphocyte loss in patients with non-small-cell lung cancer treated with modern radiotherapy techniques.</i>
                        Phys Imaging Radiat Oncol. 2024 May 27;30:100593. doi: 10.1016/j.phro.2024.100593</p>
                    <p>4. Serum miRNA-based signature indicates radiation exposure and dose in humans: A multicenter diagnostic biomarker study.
                        <b>Nowicka Z</b>, Tomasik B, Kozono D, Stawiski K, Johnson T, Haas-Kogan D, Ussowicz M, Chowdhury D, Fendler W.
                        Radiother Oncol. 2023 Aug;185:109731. doi: 10.1016/j.radonc.2023.109731</p>
                    <p>5. Elias K, Smyczynska U, Stawiski K, <b>Nowicka Z</b>, Webber J, Kaplan J, Landen C, Lubinski J, Mukhopadhyay A, Chakraborty D, Connolly DC, Symecko H, Domchek SM, Garber JE, Konstantinopoulos P, Fendler W, Chowdhury D. <i>Identification of BRCA1/2 mutation female carriers using circulating microRNA profiles.</i>
                        Nat Commun. 2023 Jun 8;14(1):3350. doi: 10.1038/s41467-023-38925-4.</p>
                    <p>6.Widmer CA, Klebic I, Domanitskaya N, Decollogny M, Howald D, Siffert M, Essers P, <b>Nowicka Z</b>, Stokar-Regenscheit N, van de Ven M, de Korte-Grimmerink R, Galván JA, Pritchard CEJ, Huijbers IJ, Fendler W, Vens C, Rottenberg S. <i> Loss of the volume-regulated anion channel components LRRC8A and LRRC8D limits platinum drug efficacy.</i>
                        Cancer Res Commun. 2022 Oct 26;2(10):1266-1281. doi: 10.1158/2767-9764.CRC-22-0208</p>
                    <p>7. Francica P, Mutlu M, Blomen VA, Oliveira C, <b>Nowicka Z</b>, Trenner A, Gerhards NM, Bouwman P, Stickel E, Hekkelman ML, Lingg L, Klebic I, van de Ven M, de Korte-Grimmerink R, Howald D, Jonkers J, Sartori AA, Fendler W, Chapman JR, Brummelkamp T, Rottenberg S. <i>Functional Radiogenetic Profiling Implicates ERCC6L2 in Non-homologous End Joining.</i>
                        Cell Rep. 2020 Aug 25;32(8):108068. doi: 10.1016/j.celrep.2020.108068.</p>
                    <p> </p>
                    <u><li><a href="https://pubmed.ncbi.nlm.nih.gov/?term=zuzanna+nowicka&sort=date" target="_blank">Full list</a></li></u>
                        
                </section>
                <section>
                    <h2>Contact</h2>
                    <center><p>Contact me: zuzanna.nowicka 'at' umed.lodz.pl</p></center>
                </section>
            </main>
        </div>
    </div>
    <footer>
        <p>&copy; 2025 Zuzanna Nowicka. All rights reserved.</p>
    </footer>
</body>
</html>
